SCHEMBL5111693

SCHEMBL5111693

[CH2]CCCOS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4578954 0.77
SCHEMBL21077263 0.76
SCHEMBL652039 0.74
SCHEMBL3220202 0.72
SCHEMBL21077274 0.72
SCHEMBL37465 0.71
SCHEMBL51000 0.69
SCHEMBL3682811 0.67 MEN1 (0.32)
SCHEMBL15459384 0.66
SCHEMBL22283296 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6573380-B2 Useful in photochemical polymerization, dye lasers, and electroluminescent elements KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2003-06-03 US claimed
US-20020052501-A1 4-cyanocoumarin derivatives and uses thereof KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2002-05-02 US claimed
EP-1041074-A1 Light-sensitive 4-cyanocoumarin derivatives KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2000-10-04 EP claimed
US-11083728-B2 Compositions of cyclin dependent kinase 7 (CDK7) inhibitor SYROS PHARMACEUTICALS, INC. (US) 2021-08-10 US disclosed
US-20200108067-A1 COMPOSITIONS OF CYCLIN DEPENDENT KINASE 7 (CDK7) INHIBITOR OXFORD FINANCE LLC, AS COLLATERAL AGENT 2020-04-09 US disclosed
EP-2718395-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2014-04-16 EP disclosed
WO-2012168395-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2012-12-13 WO disclosed
CN-101808629-A Method for activating regulatory T-cells IMTM GMBH 2010-08-18 CN disclosed
US-7375225-B2 4-cyanocoumarin derivatives and uses thereof KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2008-05-20 US disclosed
US-7166422-B2 Silver halide color photographic material, and method of image formation FUJI PHOTO FILM CO., LTD. (JP) 2007-01-23 US disclosed
EP-1093475-B1 CATALYST FOR THE POLYMERISATION OF OLEFINS BOREALIS TECH OY (FI) 2004-11-17 EP disclosed
EP-1078926-A1 PYRAN DERIVATIVES Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2001-02-28 EP disclosed
EP-1052261-A1 PYRAN DERIVATIVES AND USE THEREOF Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2000-11-15 EP disclosed
EP-1041074-A1 Light-sensitive 4-cyanocoumarin derivatives KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2000-10-04 EP disclosed
US-6110918-A TREATMENT OF PSYCHOLOGICAL DISORDERS PFIZER INC (US) 2000-08-29 US disclosed
WO-2000001739-A1 CATALYST FOR THE POLYMERISATION OF OLEFINS BOREALIS TECHNOLOGY OY (FI) 2000-01-13 WO disclosed
EP-0918772-A1 MESYLATE DIHYDRATE SALTS OF 5-(2-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL)-ETHYL)-6-CHLORO-1,3-DIHYDRO-2(1H)-INDOL-2-ONE (=ZIPRASIDONE), ITS PREPARATION AND ITS USE AS DOPAMINE D2 ANTAGONIST PFIZER INC. (US) 1999-06-02 EP disclosed
EP-0904273-A1 MESYLATE TRIHYDRATE SALT OF 5-(2-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL)ETHYL)-6-CHLORO-1,3-DIHYDRO-2(1H)-INDOL-2-ONE (=ZIPRASIDONE), ITS PREPARATION AND ITS USE AS DOPAMINE D2 ANTAGONIST PFIZER INC. (US) 1999-03-31 EP disclosed
WO-1997042190-A1 MESYLATE TRIHYDRATE SALT OF 5-(2-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL)ETHYL)-6-CHLORO-1,3-DIHYDRO-2(1H)-INDOL-2-ONE (=ZIPRASIDONE), ITS PREPARATION AND ITS USE AS DOPAMINE D2 ANTAGONIST PFIZER INC. (US) 1997-11-13 WO disclosed
WO-1997042191-A1 MESYLATE DIHYDRATE SALTS OF 5-(2-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL)-ETHYL)-6-CHLORO-1,3-DIHYDRO-2(1H)-INDOL-2-ONE (=ZIPRASIDONE), ITS PREPARATION AND ITS USE AS DOPAMINE D2 ANTAGONIST PFIZER INC. (US) 1997-11-13 WO disclosed